CMS nominee Dr. Oz faces tough questions on taxes and Medicare in confirmation hearing
President Trump’s pick to lead CMS defends his record amid tax, policy questions.
Related Articles
Organon Expands Portfolio With Biosimilar Tocilizumab-bavi for Arthritis and COVID-19
Tocilizumab-bavi received FDA approval in September 2023 as the first biosimilar to tocilizumab for the treatment of various adult and pediatric arthritis conditions.
AI-powered device hits 500,000-scan milestone
Predictmedix cites growing role in health and safety for its device’s success
Breaking Down Lipid Storage in Triple Negative Breast Cancer Cells May Help Overcome Treatment Resistance
Fatty acid metabolism plays a critical role in treatment responses.
Physician burnout getting better, but still a major problem in U.S. health care
Data for 2023 show decrease from 2021, but doctors still experience more burnout than other workers, survey finds.
ACP Hospitalist
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
FDA Issues Complete Response Letter to Manufacturer of Reproxalap, Treatment for Dry Eye Disease, Allergic Conjunctivitis
No manufacturing or safety issues were identified, but the FDA stated the new drug application did not demonstrate efficacy in adequate and well-controlled studies.
Trump says tariffs on pharmaceuticals coming soon
Are your patients’ medications about to get more expensive?
Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis | NEJM
Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral inflammation and persistent immune activation within the central nervous system,…
Study Finds ADHD Stimulants Have Minimal Effect on Cardiovascular System
Small changes in blood pressure and pulse were shown in patients of all ages, and the authors suggested that these are monitored carefully in patients…